Alnylam Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR IMPROVING STRAND BIASED

Last updated:

Abstract:

One aspect of the present invention relates to double-stranded RNA (dsRNA) agent capable of inhibiting the expression of a target gene. Other aspects of the invention relate to pharmaceutical compositions comprising these dsRNA molecules suitable for therapeutic use, and methods of inhibiting the expression of a target gene by administering these dsRNA molecules, e.g., for the treatment of various disease conditions.

Status:
Application
Type:

Utility

Filling date:

7 May 2019

Issue date:

5 Aug 2021